Skip to content

Clinical trials

Phase 2 Hyperphagia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperphagia Phase: Phase 2 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20061
20071
20093
20111
20152
20182
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3
Recruiting2
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Rhythm Pharmaceuticals, Inc.2
Australian and New Zealand Intensive Care Research Centre1
B. Braun Melsungen AG1
CONKO-Studiengruppe1
Duke University1
Emory University1
Eric Hollander1
Insel Gruppe AG, University Hospital Bern1
Massachusetts General Hospital1
Montefiore Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperphagia16
Prader-Willi Syndrome5
Cholestasis2
Critical Illness2
Liver Diseases2
Obesity2
Abdominal Injuries1
Binge-Eating Disorder1
Colitis1
Cross Infection1

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.